Ellis Investment Partners, LLC
Source: SEC Form 13F · as of Mar 2026Ellis Investment Partners, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $14.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$14.8M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 25,102 | $3.0M |
| JNJJOHNSON & JOHNSON | 7,480 | $1.8M |
| INCYIncyte Corp. | 18,264 | $1.7M |
| ABBVAbbVie Inc. | 7,529 | $1.6M |
| AMGNAMGEN INC | 4,047 | $1.4M |
| JAZZJazz Pharmaceuticals plc | 6,912 | $1.3M |
| PMPhilip Morris International Inc | 6,188 | $1.0M |
| LLYELI LILLY & Co | 961 | $885K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,542 | $688K |
| ABTABBOTT LABORATORIES | 3,877 | $398K |
| WSTWest Pharmaceutical Services Inc. | 1,411 | $354K |
| BMYBRISTOL MYERS SQUIBB CO | 4,683 | $284K |
| PFEPFIZER INC | 8,561 | $240K |
| ELDNEledon Pharmaceuticals, Inc. | 10,000 | $31K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.